20th Valve Disease, Structural Interventions and Diastology Summit – Cleveland Clinic 2018
MedicalVideo
$40.00
Description
YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT
20th Valve Disease, Structural Interventions and Diastology Summit – Cleveland Clinic 2018
Topics And Speakers:
Session 1: Valve Disease – Focus on Aortic Stenosis I
| Aortic Stenosis: What Criteria Directs Which Treatment? | David Rubenson, MD, FACC, FASE |
| Mechanism of Aortic Stenosis: Degenerative, Atherosclerosis, or Inflammation | Gian M. Novaro, MD, FACC, FASE |
| TAVR Is a Team Sport: The Dynamics of the Heart Valve Team | Stephanie Mick, MD |
| 3D Echo and MDCT Imaging for TAVR | Milind Desai, MD |
| Is TAVR Applicable in Lower Risk Groups? | Jonathon White, MD |
| Paravalvular Regurgitation in TAVR: Prediction, Prevention, Quantitation and Management | Linda Gillam, MD, MPH, FACC, FASE, FESC |
| Valve in Valve TAVR – Another Plus for Bioprostheses at First Operation? | Robert Cubeddu, MD |
Session 2: Valve Disease—Focus on Aortic Stenosis II
| Intraprocedural TEE in SAVR and TAVR: Incremental Benefit or Essential Tool? | Linda Gillam, MD, MPH, FACC, FASE, FESC |
| Thoracic Aortic Disease – When CT, MR, TTE, TEE? | Milind Desai, MD |
| Ascending Aortic Dilation – A Concomitant of Aortic Valve Disease | Gian M. Novaro, MD, FACC, FASE |
| Paradoxical or Not: Low Flow, Low Gradient Aortic Stenosis (AS) | William J. Stewart, MD, FACC, FASE |
| Transcatheter Procedures – What to Do When the Awful Happens | Jonathon White, MD |
| Dobutamine Echo in Aortic Stenosis – Indications, Methods, Impact on Management | Brian Griffin, MD, FACC |
| Panel Discussion |
Session 3: Aortic Stenosis Case Workshop
| How to Do an AS Exam For Sonographers | Deborah A. Agler, ACS, RDCS, FASE |
| Management of TAVR Paravalvular Leak | Robert Cubeddu, MD |
| AS, HOCM, or Not? | Milind Desai, MD |
| Watchman LAA Closure | Konstantinos P. Koulogiannis, MD |
| Severe Aortic Stenosis | Stephanie Mick, MD |
Session 4: Diastolic Dysfunction and Right Heart Function I
| Updated Guidelines for Assessment of LV Filling Pressure | Sherif Nagueh, MD |
| Practical Approach to Diastolic Function: Limitations and Pitfalls | Deborah A. Agler, ACS, RDCS, FASE |
| Estimating LV Filling Pressures By Echocardiography | Milind Desai, MD |
| Constriction and Amyloid: Diastolic Dysfunction | Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE, FESC |
| Diastolic Dysfunction and LVOT Gradients in Hypertrophic Cardiomyopathy | Sherif Nagueh, MD |
| Hemodynamic Correlates of Diastolic Dysfunction: What do the Studies Show? | Sherif Nagueh, MD |
| Diastolic Dysfunction in Special Populations: Atrial Fibrillation, MV Disease, Transplant, Pulmonary Hypertension | William J. Stewart, MD, FACC, FASE |
| Panel Discussion |
Session 5: Diastolic Dysfunction and Right Heart Function II
| Athletic Heart vs. Varied Faces of Hypertrophic Cardiomyopathy | Milind Desai, MD |
| Complicated Pericarditis: A New Imaging Guided Approach | Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE, FESC |
| Clinical Presentation of Right Sided Heart Disease – “Look-alikes” | Linda Gillam, MD, MPH, FACC, FASE, FESC |
| Tricuspid Valve Dysfunction- Subtypes and Outcomes | David Rubenson, MD, FACC, FASE |
| Aortic Valve: Replace, Repair? | Stephanie Mick, MD |
| Transcatheter Tricuspid Interventions: The Forgotten Valve No Longer! | Hector I. Michalena, MD, FACC, FASE |
| Role of Contrast Echo in Assessing Left and Right Heart Function | Deborah A. Agler, ACS, RDCS, FASE |
| Panel Discussion |
Session 6: Constriction, Restriction, Tricuspid Regurgitation and Contrast Echo Cases
| Tricuspid Valve 1 | Konstantinos P. Koulogiannis, MD |
| HOCM | Deborah A. Agler, ACS, RDCS, FASE |
| Multivalve Disease | David Rubenson, MD, FACC, FASE |
| Severe Symptomatic TR | Brian Griffin, MD, FACC |
| Diastolic Heart Failure | Robert Cubeddu, MD |
| Percutaneous Valvuloplasty For Mitral Stenosis | Sherif Nagueh, MD |
| Cardio Oncology | Diego Sadler, MD, FACC, FACP |
| Functional Tricuspid Regurgitation | William J. Stewart, MD, FACC, FASE |
| Tricuspid Valve 2 | Konstantinos P. Koulogiannis, MD |
Session 7: Valve Regurgitation, 3D Echo and Strain I
| State of the Art Echo Quantification of Mitral and Aortic Regurgitation | Linda Gillam, MD, MPH, FACC, FASE, FESC |
| Aortic Regurgitation – Decisions Based on Clinical and Echo Data | Brian Griffin, MD, FACC |
| Surgical Considerations in Mitral Regurgitation | Stephanie Mick, MD |
| Asymptomatic Severe Mitral Regurgitation: Choosing the Golden Moment | William J. Stewart, MD, FACC, FASE |
| Exercise Testing in Mitral or Aortic Valve Disease: What do the Guidelines Say? | David Rubenson, MD, FACC, FASE |
| Mitraclip: The New Mitral Repair | Hector Michalena, MD, FACC, FASE |
| Percutaneous Mitral and Tricuspid Valve Therapies and Paravalvular Leak Closure | Jonathon White, MD |
| Panel Discussion |
Session 8: Valve Regurgitation, 3D Echo and Strain II
| Incorporating 3D Echo and LV Strain into Routine Practice in the Echo Lab | Deborah A. Agler, ACS, RDCS, FASE |
| 3D Echo: How to Acquire Data with Each of 3 Vendors | Konstantinos P. Koulogiannis, MD |
| Unique Skills of 3D Echo over 2D: Which Situations? | William J. Stewart, MD, FACC, FASE |
| Myocardial Mechanics: Strain and Torsion in Clinical Practice | Sherif Nagueh, MD |
| LV Strain in Cardio-Oncology | Diego Sadler, MD, FACC, FACP |
| Muscle Mechanics in Pericardial Disease | Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE, FESC |
| Panel Discussion |
Session 9: Radiation, Contrast Echo and MR Treatment Cases
| Newer Treatment Options For Recurrent Pericarditis | Chandra Kanth Ala, MD |
| Transcatheter Mitral Valve Replacement | Cliff Chun Pong Wong, MD |
| Will I Get Better With Heart Surgery? | Beni R. Verma, MD |
| Valvular Heart Disease | Konstantinos P. Koulogiannis, MD |
| P2 Prolapse Repair | Brian Griffin, MD, FACC |
Release Date: 5/15/18
CME Expiration: 5/14/20